Larvol Delta - A-phase-2-randomized-doubleblind-placebocontrolled-study-to-assess-the-tolerability-and-pharmacodynamic-effects-of-CRD740-a-PDE9-inhibitor-in-participants-with-chronic-heart-failure

CRD-740 - Cardurion

https://digital-congress.escardio.org/ESC-Congress/sessions/11712

James E Udelson

May 14, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next